What is 'Stock And Warrant Off-Balance Sheet R&D - SWORD'

Stock And Warrant Off-Balance Sheet R&D (SWORD) is a form of financing that helps biotechnology firms access research and development funding while reducing risk to the company. Innovation is a key characteristic for biotech firms to remain competitive in the market, and SWORD financing provides young firms an avenue to create and control their own research sponsors.

BREAKING DOWN 'Stock And Warrant Off-Balance Sheet R&D - SWORD'

Stock And Warrant Off-Balance Sheet R&D (SWORD) is a financing option developed to help biotechnology companies access capital for research and development. SWORD financing establishes a separate entity with the purpose of raising research and development funding.

SWORD financing benefits biotech companies, particularly young companies with little capital on hand, by facilitating the development projects they would otherwise be unable to afford, and reducing the risk to current shareholders.  SWORDs allow companies to minimize the effects of R&D spending on the firm's bottom line.

Investors, often institutional investors or wealthy individuals speculating on emerging technologies, typically benefit from the SWORD approach by receiving a portion of the rights to the R&D outcomes. In some cases, investors will also receive warrants on stock in the parent company.
A typical SWORD agreement establishes an entity serving as a middleman between the biotech firm and the R&D investors. The SWORD will own the property rights to the R&D, usually providing a license in perpetuity to the biotech firm to use the technologies as they develop products and projects. The financial obligations of the SWORD remain fully separate from the parent firm, and financing for this separate entity ultimately comes from a public offering. A SWORD owning a successful technology could then effectively be bought back by the parent company by calling on common stock.

SWORD Impact on Biotechnology and Innovation

As we have seen, SWORD financing provides an important layer of financial security to biotechnology companies, which rely on research and development to remain competitive. The biotechnology sector consists of firms engaged in a wide range of industries, including medicine, pharmaceuticals, food and fuel. Rooted in principles of understanding and manipulating the ways living organisms function, biotechnology has been responsible for enormous advances in areas such as disease control, crop yields, pollution control and human lifespan.

As an economic sector, innovation is a crucial aspect for biotech firms to remain competitive in the market. The risks are high, and the margins are slim, especially for young companies. More traditional forms of funding research and development, including venture capital, strategic alliances, equity financing or debt financing present unattractive barriers to small firms looking to retain control of their company and its returns.

RELATED TERMS
  1. Financing Entity

    A financing entity is the party in a financing arrangement that ...
  2. Return On Research Capital - RORC

    Return On Research Capital is a measure to assess the revenue ...
  3. Equity Financing

    If a company needs capital to support its growth, it might seek ...
  4. Price-To-Innovation-Adjusted Earnings

    A variation of the price-to-earnings ratio (P/E ratio) that takes ...
  5. Project Finance

    Defined by the International Project Finance Association (IPFA) ...
  6. Corporate Finance

    Corporate finance is the division of a company that deals with ...
Related Articles
  1. Insurance

    How To Do Qualitative Analysis On Biotech Companies

    These analytical methods will help you size up a biotech company and make a winning investment.
  2. Financial Advisor

    Investing In Biotech: Is It Worth The Risk?

    Investors shunned biotech after a weak start in 2014. Now that a comeback is in the works, should they reconsider?
  3. Investing

    Buying Into Corporate Research & Development (R&D)

    Investors take note: companies that cut research and development are in danger of saving today but losing big tomorrow.
  4. Investing

    The Top 5 Biotechnology ETFs for 2016 (XBI, IBB)

    Read analyses of the top biotech ETFs for 2016, and learn about the characteristics of the funds that may be poised to rebound.
  5. Investing

    XBI: SPDR S&P Biotech ETF

    Discover the investment management style of SPDR S&P Biotech ETF, and learn which investors can benefit from the fund's focused biotech holdings.
  6. Investing

    A Quick Guide To Healthcare ETFs

    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and biotechnology .
  7. Trading

    Biotech Breakouts Suggest It Is Time to Buy

    Bullish chart patterns on key biotech names are presenting traders with the best risk/reward setup of 2017.
  8. Insights

    And The King of R&D Spending Is

    When it comes to investing in other countries, knowing how much is being spent on research and development, and where it's be spent, is important for any investor.
  9. Insights

    Pharmaceutical Vs. Biotech Investing: Is It Worth The Risk?

    Investopedia explains: Both pharma and biotech stocks are faced with a costly process that, when successful, can produce extremely profitable products. However, the process is unpredictable.
RELATED FAQS
  1. What is finance?

    Finance is the study of how money is managed and the process of acquiring needed funds. Personal finance, corporate finance ... Read Answer >>
  2. How are stock warrants different from stock options?

    Stock option and stock warrant may have similar function. However, company uses these two financial instruments for different ... Read Answer >>
  3. What are the benefits and shortfalls of the Herfindahl-Hirschman Index?

    Learn about the differences between equity and debt financing and how they impact financials. Find out how businesses determine ... Read Answer >>
  4. Is debt a relatively cheaper form of finance than equity?

    When financing a company, the cost of obtaining capital comes through debt or equity. Find out which method generally provides ... Read Answer >>
  5. What is the difference between the cost of capital and the discount rate?

    Learn about the differences between the cost of capital and the discount rate as they relate to estimating a required return ... Read Answer >>
Hot Definitions
  1. Quick Ratio

    The quick ratio measures a company’s ability to meet its short-term obligations with its most liquid assets.
  2. Leverage

    Leverage results from using borrowed capital as a source of funding when investing to expand the firm's asset base and generate ...
  3. Financial Risk

    Financial risk is the possibility that shareholders will lose money when investing in a company if its cash flow fails to ...
  4. Enterprise Value (EV)

    Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market ...
  5. Relative Strength Index - RSI

    Relative Strength Indicator (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent ...
  6. Dividend

    A dividend is a distribution of a portion of a company's earnings, decided by the board of directors, to a class of its shareholders.
Trading Center